Concepedia

Luis Rojas‐Espaillat

LR

11

Publications

426

Citations

10

H-Index

2005

Active since

Affiliations

Cleveland Clinic(Current)

University of North Carolina at Chapel Hill

Avera Health

Luis Rojas‐Espaillat is an author at Cleveland Clinic specializing in medicine, obstetrics, and cancer therapeutics.

Top concepts

Publications per year

2005–2022

11

Publications

11

Laparoendoscopic single-site surgery (LESS) in gynecology: a multi-institutional evaluation

Amanda N. Fader, Luis Rojas‐Espaillat, Okechukwu A. Ibeanu et al. · American Journal of Obstetrics and Gynecology · 2010 · 136 citations

, , +5

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

Ignace Vergote, Giovanni Scambia, David M. O’Malley et al. · The Lancet Oncology · 2019 · 85 citations · Full text

, , +9

Optical coherence tomography as a diagnostic aid to visual inspection and colposcopy for preinvasive and invasive cancer of the uterine cervix

Pedro F. Escobar, Luis Rojas‐Espaillat, S. Tisci et al. · International Journal of Gynecological Cancer · 2006 · 61 citations

CCL2 expression in primary ovarian carcinoma is correlated with chemotherapy response and survival outcomes.

Amanda N. Fader, Nabila Rasool, S. A. Vaziri et al. · PubMed · 2010 · 44 citations

, , +11

Phase I dose escalation study of dual PI3K/mTOR inhibition by Sapanisertib and Serabelisib in combination with paclitaxel in patients with advanced solid tumors

David Starks, Luis Rojas‐Espaillat, Casey Williams · Gynecologic Oncology · 2022 · 20 citations · Full text

Rows per page

1–5 of 11